Holy Cross Health (Site 1072), 4725 North Federal Highway — Fort Lauderdale, Florida

Holy Cross Health (Site 1072), 4725 North Federal Highway is a clinical research site located in Fort Lauderdale, Florida, United States 33308.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Holy Cross Health (Site 1072), 4725 North Federal Highway has participated in 1 clinical trials.

Therapeutic areas: Coronavirus, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Lauderdale

Browse all research sites in Florida · View every site in Fort Lauderdale

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Holy Cross Health (Site 1072), 4725 North Federal Highway?

Holy Cross Health (Site 1072), 4725 North Federal Highway has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Holy Cross Health (Site 1072), 4725 North Federal Highway conducted?

Holy Cross Health (Site 1072), 4725 North Federal Highway has 1 clinical trials on record. Their work covers Coronavirus, Covid19.

Is Holy Cross Health (Site 1072), 4725 North Federal Highway accredited by Crixeo Clinical Trials?

Holy Cross Health (Site 1072), 4725 North Federal Highway has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Holy Cross Health (Site 1072), 4725 North Federal Highway?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.